Brian F. Gage
Brian F. Gage
Professor of Medicine, Washington University in St. Louis
Verified email at - Homepage
Cited by
Cited by
Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation
BF Gage, AD Waterman, W Shannon, M Boechler, MW Rich, MJ Radford
Jama 285 (22), 2864-2870, 2001
Estimation of the warfarin dose with clinical and pharmacogenetic data
International Warfarin Pharmacogenetics Consortium
New England Journal of Medicine 360 (8), 753-764, 2009
Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose
MJ Rieder, AP Reiner, BF Gage, DA Nickerson, CS Eby, HL McLeod, ...
New England Journal of Medicine 352 (22), 2285-2293, 2005
Baseline risk of major bleeding in non–ST-segment–elevation myocardial infarction: the CRUSADE (can rapid risk stratification of unstable angina patients suppress ADverse …
S Subherwal, RG Bach, AY Chen, BF Gage, SV Rao, LK Newby, TY Wang, ...
Circulation 119 (14), 1873-1882, 2009
Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF)
BF Gage, Y Yan, PE Milligan, AD Waterman, R Culverhouse, MW Rich, ...
American heart journal 151 (3), 713-719, 2006
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin
BF Gage, C Eby, JA Johnson, E Deych, MJ Rieder, PM Ridker, ...
Clinical Pharmacology & Therapeutics 84 (3), 326-331, 2008
Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin
BF Gage, C Van Walraven, L Pearce, RG Hart, PJ Koudstaal, BSP Boode, ...
Circulation 110 (16), 2287-2292, 2004
The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis
Meta-analysis Global Group in Chronic Heart Failure (MAGGIC)
European heart journal 33 (14), 1750-1757, 2012
A pharmacogenetic versus a clinical algorithm for warfarin dosing
SE Kimmel, B French, SE Kasner, JA Johnson, JL Anderson, BF Gage, ...
New England Journal of Medicine 369 (24), 2283-2293, 2013
Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial
SPS3 Study Group
The Lancet 382 (9891), 507-515, 2013
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing
JA Johnson, L Gong, M Whirl‐Carrillo, BF Gage, SA Scott, CM Stein, ...
Clinical Pharmacology & Therapeutics 90 (4), 625-629, 2011
Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors
E Birman-Deych, AD Waterman, Y Yan, DS Nilasena, MJ Radford, ...
Medical care, 480-485, 2005
Independent predictors of stroke in patients with atrial fibrillation: a systematic review
Stroke Risk in Atrial Fibrillation Working Group
Neurology 69 (6), 546-554, 2007
CYP4F2 genetic variant alters required warfarin dose
MD Caldwell, T Awad, JA Johnson, BF Gage, M Falkowski, P Gardina, ...
Blood, The Journal of the American Society of Hematology 111 (8), 4106-4112, 2008
Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for pharmacogenetics‐guided warfarin dosing: 2017 update
JA Johnson, KE Caudle, L Gong, M Whirl‐Carrillo, CM Stein, SA Scott, ...
Clinical Pharmacology & Therapeutics 102 (3), 397-404, 2017
The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life
BF Gage, AB Cardinalli, DK Owens
Archives of internal medicine 156 (16), 1829-1836, 1996
Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin
BF Gage, C Eby, PE Milligan, GA Banet, JR Duncan, HL McLeod
Thrombosis and haemostasis 91 (01), 87-94, 2004
Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation
SV Shah, BF Gage
Circulation 123 (22), 2562-2570, 2011
Warfarin genotyping reduces hospitalization rates: results from the MM-WES (Medco-Mayo Warfarin Effectiveness Study)
RS Epstein, TP Moyer, RE Aubert, DJ O'Kane, F Xia, RR Verbrugge, ...
Journal of the American College of Cardiology 55 (25), 2804-2812, 2010
Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation
BF Gage, M Boechler, AL Doggette, G Fortune, GC Flaker, MW Rich, ...
Stroke 31 (4), 822-827, 2000
The system can't perform the operation now. Try again later.
Articles 1–20